Navigation Links
Clinverse, Inc. Celebrates Five-Year Anniversary, Doubling Revenue Year-Over-Year

Durham, NC (PRWEB) December 04, 2013

Clinverse, Inc., provider of the first end-to-end, cloud-based financial lifecycle system for automating global clinical payments, celebrates its five-year anniversary with tremendous growth momentum, on track to double revenue year-over-year in 2013, and projected to again double revenue in 2014.

Momentum is clearly building on the global client front. Clinverse is currently contracted to facilitate site payments to thousands of global clinical trial sites in more than 40 countries. The number of ClinPay clients has more than doubled in 2013, and is again expected to do so in 2014. In Q2 2013, a top 5 global biotech implemented ClinPay to automate site payments in 25 countries, and several other enterprise-level contracts are currently in negotiation.

Clinverse has been on a hiring trajectory, nearly doubling its staff over the past year to support its growth. Seasoned, industry veterans joined the executive team, further solidifying the company’s position as the original innovator of automated global clinical payment systems. Clinverse hired and incorporated a structured sales and marketing organization, while also growing its in-house development team by 38% in 2013. In September, Clinverse moved its headquarters to a new location in Durham, NC, more than doubling the size of its previous office space.

Clinverse will continue to expand its financial lifecycle system, with the addition of two product modules to be released in 2014. ClinView will allow sites with approved access to gain real-time views into their respective paid financial history. Clinverse’s Budgeting and Forecasting module will develop and maintain investigator payment budgets, and then apply that data to future trial expectations to provide a financial forecast.

“As pioneers in SaaS-based clinical payment technology, we have our finger on the pulse of what’s happening in the industry, and we’re well-equipped to anticipate and provide innovative solutions that our clients really need,” said Denis Connaghan, CEO, Clinverse. “By providing real-time visibility into our clients’ financial outlook and a greater level of control over their financial data than ever before, not only do they have a higher level of confidence, they are also experiencing significant time savings and resource efficiencies – all critical for success and moving forward to the next phase of their clinical trial.”

Clinverse also executed on its formal partnership strategy over the course of the year, teaming with other innovative and forward-thinking companies, allowing the company to expand its global footprint and reach a broader audience of pharmaceutical and biotech companies who can greatly benefit from automated payment capabilities in conjunction with partner solutions and services. In addition to an existing relationship with Medidata, Clinverse announced a strategic partnership with EDC provider, OmniComm Systems, Inc. in September. This integrated solution eliminates the potential for errors and reduces costs for sponsors for using EDC data to trigger automated payments.

Clinverse recently conducted a highly successful webinar on putting contract terms to work to improve clinical trial performance. The presentation featured the expertise of two prominent industry thought leaders, Christine Pierre, President of the Society for Clinical Research Sites (SCRS), and Serena Lau, Principal Associate at RH Bouchard & Associates. The company plans to continue its series of Best Practices in the Financial Lifecycle of Your Clinical Trial in 2014 with additional whitepapers and webinars.

“This has been an amazing year for Clinverse, one in which we’ve seen many changes in the marketplace,” commented Connaghan. “We spent more than two years developing and refining our core technology before ever going to market, and we’re now seeing market demand catching up to the industry. We’re educating the marketplace that a best-in-class solution to automate the clinical trial financial lifecycle exists, and will continue to incorporate innovative practices moving forward in 2014.”

About Clinverse, Inc.
Clinverse, Inc. offers the industry’s first end-to-end, cloud-based financial lifecycle system for automating clinical payments globally. Used by leading BioPharma companies, our clients benefit from reduced costs through automated financial processing and unprecedented transparency and workflow. Powered by our highly secure technology platform, our solution manages millions of global financial transactions in 140 different currencies. For more information, please visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinverse, Inc. Hosting Complimentary Webinar on Sensible Clinical Trial Management
2. Clinverse, Inc. Announces Strategic Partnership With OmniComm Systems, Inc.
3. Denis Connaghan Joins Clinverse, Inc. as Chief Executive Officer
4. Bud Owen and Tony Click Join Clinverse, Inc. as Chief Financial Officer and Chief Technology Officer
5. Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013
6. Clinverse, Inc. Introduces ClinSpend to Meet Challenges of Sunshine Act Reporting Requirements
7. Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC
8. CSafe Global Celebrates Six-Year Anniversary of RKN FAA Approval and Launch of Fleet
9. OBNs 2013 Annual Awards Dinner Celebrates UK Bioscience Success Stories
10. JULABO USA Celebrates 20 Years in the U.S.A.
11. Cato Research Celebrates 25 Years of Successful Life Science Research and Development
Post Your Comments:
(Date:10/9/2015)... Oct. 9, 2015  Pulmatrix, Inc., (NASDAQ: PULM ) ... investor conferences. th Annual BIO Investor ... (2:00 pm EDT). --> th Annual ... am PDT (2:00 pm EDT). --> Pulmatrix ... Growth Stock Conference on Thursday, October 15, 2015 at 8:30 ...
(Date:10/9/2015)... ... October 09, 2015 , ... Leading microbial genomics startup uBiome today ... understand the relationship between weight management and the microbiome. The study uses the ResearchKit ... using an iPhone app. , The uBiome app is available as a free download ...
(Date:10/8/2015)... Fla. , Oct. 8, 2015   Intrexon ... synthetic biology, today announced the appointment of Joseph ... Environment Sector, succeeding Nir Nimrodi who continues ... Vaillancourt will direct Intrexon,s endeavors to generate sustainable, biologically ... America , where he held a variety of ...
(Date:10/8/2015)... , Oct. 8, 2015  Genetic testing for mutations ... the identification of more couples at risk of having ... presented today at the 2015 American Society of Human ... in Baltimore, Maryland . The study ... (NYSE: DGX ) are presenting at the conference ...
Breaking Biology Technology:
... (a subsidiary of Elan Corporation, plc) ( ELN) ("Elan") to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal infusion). , ... , , ... ... ...
... ... Be Discussed and Demonstrated at Philadelphia Conference , ... Chicago, IL (PRWEB) March 11, 2010 -- ClearTrial, the ... panel discussion which includes pharmaceutical analysts from Deutsche Bank and Cowen & Company at ...
... TORONTO , March 11 /PRNewswire/ - Trillium Therapeutics ... announced that it has entered into two definitive license agreements ... Children (SickKids) in Toronto, Ontario , granting Trillium exclusive ... of hematopoietic stem cell transplantation and cancer. , ...
Cached Biology Technology:
(Date:10/7/2015)... Sweden , October 8, 2015 ... the revenues for Fingerprint Cards (FPC) during third quarter 2015 ... revenue guidance of around 860 MSEK that was communicated 20 ... Considering a further strengthened delivery capacity and a continued growing ... quarter 2015 is estimated to be higher than during the ...
(Date:10/6/2015)... LAKE CITY , Oct. 6, 2015 ... company, announced today that it has signed a contract ... monitoring services across the full range of sentences under ... Group,s President of the Americas. "This contract with the ... region of the US and advances our position as ...
(Date:10/5/2015)... ) releases the following ... NXTD ), a biometric authentication company focused on the ... ) releases the following market and company update ... authentication company focused on the growing mobile commerce market. ... ) releases the following market and company update ...
Breaking Biology News(10 mins):
... the most commonly cultivated cacao plant in the world ... this week. Researchers have utilised high quality DNA sequences to ... markers that can lead to higher yielding cocoa plants that still ... the cacao tree ( Theobroma cacao L. ...
... species, according to a new study led by Woods ... published in the journal PLOS ONE . Because ... may have far-reaching effects on the ocean environment and ... the center of the ocean ecosystemnearly all animals are ...
... insecurity increases the risk of death among injection drug ... life-prolonging antiretroviral therapy (ART), according to a new study ... the peer-reviewed science journal, PLoS One , examines ... among injection drug users. Food insecurity is defined by ...
Cached Biology News:
... Software reads and processes raw ... microarray data for analysis. ... one 2-year license for Feature ... , * one CD-ROM ...
... imported for data analysis , Automatic grid, subgrid ... template assignment , ... Extensive background and signal options to optimize, ... results , ...
... DNA Gel Stain combo offers these benefits: ... products separately Offers a ... Eliminates risks to yourself, the environment ... from 100 bp to >30 kb. UltraPure Agarose is ...
... stocks contained in standard 96-well microtiter plates. ... approximately 5,000 clones per plate. After positive ... the corresponding subplate is screened with a ... well(s). Cells from a positive well are ...
Biology Products: